100 related articles for article (PubMed ID: 8297152)
1. Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
Anticancer Res; 1993; 13(6A):2319-23. PubMed ID: 8297152
[TBL] [Abstract][Full Text] [Related]
2. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
[TBL] [Abstract][Full Text] [Related]
3. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Muller D; Wolf C; Abecassis J; Millon R; Engelmann A; Bronner G; Rouyer N; Rio MC; Eber M; Methlin G
Cancer Res; 1993 Jan; 53(1):165-9. PubMed ID: 7677979
[TBL] [Abstract][Full Text] [Related]
4. Stromelysin-3 expression promotes tumor take in nude mice.
Nöel AC; Lefebvre O; Maquoi E; VanHoorde L; Chenard MP; Mareel M; Foidart JM; Basset P; Rio MC
J Clin Invest; 1996 Apr; 97(8):1924-30. PubMed ID: 8621777
[TBL] [Abstract][Full Text] [Related]
5. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
6. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.
Polette M; Clavel C; Cockett M; Girod de Bentzmann S; Murphy G; Birembaut P
Invasion Metastasis; 1993; 13(1):31-7. PubMed ID: 8407209
[TBL] [Abstract][Full Text] [Related]
7. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
Andarawewa KL; Motrescu ER; Chenard MP; Gansmuller A; Stoll I; Tomasetto C; Rio MC
Cancer Res; 2005 Dec; 65(23):10862-71. PubMed ID: 16322233
[TBL] [Abstract][Full Text] [Related]
8. [Significance of membrane type-1 matrix metalloproteinase expression in breast cancer].
Yao GY; Yang MT; Rong TH; He P
Ai Zheng; 2004 Nov; 23(11 Suppl):1482-6. PubMed ID: 15566663
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
[TBL] [Abstract][Full Text] [Related]
10. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
11. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
12. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
Autio-Harmainen H; Karttunen T; Hurskainen T; Höyhtyä M; Kauppila A; Tryggvason K
Lab Invest; 1993 Sep; 69(3):312-21. PubMed ID: 8377473
[TBL] [Abstract][Full Text] [Related]
13. Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Nakopoulou L; Panayotopoulou EG; Giannopoulou I; Alexandrou P; Katsarou S; Athanassiadou P; Keramopoulos A
Mod Pathol; 2002 Nov; 15(11):1154-61. PubMed ID: 12429794
[TBL] [Abstract][Full Text] [Related]
14. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions.
Uría JA; Ståhle-Bäckdahl M; Seiki M; Fueyo A; López-Otín C
Cancer Res; 1997 Nov; 57(21):4882-8. PubMed ID: 9354453
[TBL] [Abstract][Full Text] [Related]
15. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
17. Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.
Wang CS; Têtu B
Int J Cancer; 2002 Jun; 99(6):792-9. PubMed ID: 12115479
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
[TBL] [Abstract][Full Text] [Related]
20. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
